268 related articles for article (PubMed ID: 26886923)
1. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
[TBL] [Abstract][Full Text] [Related]
3. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
[TBL] [Abstract][Full Text] [Related]
4. Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.
Schmidt A; Marabita F; Kiani NA; Gross CC; Johansson HJ; Éliás S; Rautio S; Eriksson M; Fernandes SJ; Silberberg G; Ullah U; Bhatia U; Lähdesmäki H; Lehtiö J; Gomez-Cabrero D; Wiendl H; Lahesmaa R; Tegnér J
BMC Biol; 2018 May; 16(1):47. PubMed ID: 29730990
[TBL] [Abstract][Full Text] [Related]
5. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.
Takaki H; Ichiyama K; Koga K; Chinen T; Takaesu G; Sugiyama Y; Kato S; Yoshimura A; Kobayashi T
J Biol Chem; 2008 May; 283(22):14955-62. PubMed ID: 18400747
[TBL] [Abstract][Full Text] [Related]
6. The T helper 17-regulatory T cell axis in transplant rejection and tolerance.
Mitchell P; Afzali B; Lombardi G; Lechler RI
Curr Opin Organ Transplant; 2009 Aug; 14(4):326-31. PubMed ID: 19448538
[TBL] [Abstract][Full Text] [Related]
7. Glutamine supplementation improves the activity and immunosuppressive action of induced regulatory T cells in vitro and in vivo.
Zhang L; Xu Z; Li Y; Wu KJ; Yu C; Zhu W; Sun DL; Zhu L; Zhou J
Transpl Immunol; 2024 Jun; 84():102044. PubMed ID: 38663757
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells.
Liu Y; Lan Q; Lu L; Chen M; Xia Z; Ma J; Wang J; Fan H; Shen Y; Ryffel B; Brand D; Quismorio F; Liu Z; Horwitz DA; Xu A; Zheng SG
J Mol Cell Biol; 2014 Feb; 6(1):81-92. PubMed ID: 23861553
[TBL] [Abstract][Full Text] [Related]
9. Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols.
Kim JI; O'connor MR; Duff PE; Zhao G; Lee KM; Eliades P; Deng S; Yeh H; Caton AJ; Markmann JF
Transplantation; 2011 Apr; 91(7):707-13. PubMed ID: 21386770
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development.
Battaglia A; Buzzonetti A; Baranello C; Fanelli M; Fossati M; Catzola V; Scambia G; Fattorossi A
Immunology; 2013 May; 139(1):109-20. PubMed ID: 23278180
[TBL] [Abstract][Full Text] [Related]
11. Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells.
Arroyo-Olarte RD; Flores-Castelán JC; Armas-López L; Escobedo G; Terrazas LI; Ávila-Moreno F; Leon-Cabrera S
Inflammation; 2024 May; ():. PubMed ID: 38700792
[TBL] [Abstract][Full Text] [Related]
12. tTregs, pTregs, and iTregs: similarities and differences.
Shevach EM; Thornton AM
Immunol Rev; 2014 May; 259(1):88-102. PubMed ID: 24712461
[TBL] [Abstract][Full Text] [Related]
13. Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy.
Zheng Y; Lebid A; Chung L; Fu J; Wang X; Otrocol A; Zarif JC; Yu H; Llosa NJ; Pardoll DM
Oncoimmunology; 2024; 13(1):2297503. PubMed ID: 38235319
[TBL] [Abstract][Full Text] [Related]
14. Combined Treatment With TGF-β1, Retinoic Acid, and Lactoferrin Robustly Generate Inducible Tregs (iTregs) Against High Affinity Ligand.
Jang YS; Park SH; Kang SG; Lee JS; Ko HJ; Kim PH
Immune Netw; 2023 Oct; 23(5):e37. PubMed ID: 37970231
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
Kishimoto TK; Fournier M; Michaud A; Rizzo G; Roy C; Capela T; Nukolova N; Li N; Doyle L; Fu FN; VanDyke D; Traber PG; Spangler JB; Leung SS; Ilyinskii PO
J Autoimmun; 2023 Nov; 140():103125. PubMed ID: 37844543
[TBL] [Abstract][Full Text] [Related]
16. The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.
Zheng SG
Int J Clin Exp Med; 2008; 1(3):192-202. PubMed ID: 19079658
[TBL] [Abstract][Full Text] [Related]
17. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells.
Pan F; Yu H; Dang EV; Barbi J; Pan X; Grosso JF; Jinasena D; Sharma SM; McCadden EM; Getnet D; Drake CG; Liu JO; Ostrowski MC; Pardoll DM
Science; 2009 Aug; 325(5944):1142-6. PubMed ID: 19696312
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation-induced regulatory programs in T cells unveiled by transcriptomic analyses.
Lysandrou M; Stamou P; Kefala D; Pierides C; Kyriakou M; Savvopoulos N; Christofi P; Papadopoulou A; Yannaki E; Costeas P; Spyridonidis A
Front Immunol; 2023; 14():1235661. PubMed ID: 37828996
[TBL] [Abstract][Full Text] [Related]
19. Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
Cobbold SP; Adams E; Farquhar CA; Nolan KF; Howie D; Lui KO; Fairchild PJ; Mellor AL; Ron D; Waldmann H
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12055-60. PubMed ID: 19567830
[TBL] [Abstract][Full Text] [Related]
20. PRMT5 regulates epigenetic changes in suppressive Th1-like iTregs in response to IL-12 treatment.
Jadon N; Shanthalingam S; Tew GN; Minter LM
Front Immunol; 2023; 14():1292049. PubMed ID: 38259494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
